Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Urinary liver-type fatty acid-binding protein level as a predictive biomarker of contrast-induced acute kidney injury.

Manabe K, Kamihata H, Motohiro M, Senoo T, Yoshida S, Iwasaka T.

Eur J Clin Invest. 2012 May;42(5):557-63. doi: 10.1111/j.1365-2362.2011.02620.x. Epub 2011 Nov 10.

PMID:
22070248
2.

[Urinary L-type fatty acid binding protein (L-FABP) as a new urinary biomarker promulgated by the Ministry of Health, Labour and Welfare in Japan].

Kamijo-Ikemori A, Ichikawa D, Matsui K, Yokoyama T, Sugaya T, Kimura K.

Rinsho Byori. 2013 Jul;61(7):635-40. Review. Japanese.

PMID:
24205707
3.

Urinary L-type fatty acid-binding protein as a new renal biomarker in critical care.

Doi K, Noiri E, Sugaya T.

Curr Opin Crit Care. 2010 Dec;16(6):545-9. doi: 10.1097/MCC.0b013e32833e2fa4. Review.

PMID:
20736829
4.

Urinary fatty acid binding protein in renal disease.

Kamijo-Ikemori A, Sugaya T, Kimura K.

Clin Chim Acta. 2006 Dec;374(1-2):1-7. Epub 2006 Jun 3. Review.

PMID:
16860300
5.

Urinary, Plasma, and Serum Biomarkers' Utility for Predicting Acute Kidney Injury Associated With Cardiac Surgery in Adults: A Meta-analysis.

Ho J, Tangri N, Komenda P, Kaushal A, Sood M, Brar R, Gill K, Walker S, MacDonald K, Hiebert BM, Arora RC, Rigatto C.

Am J Kidney Dis. 2015 Dec;66(6):993-1005. doi: 10.1053/j.ajkd.2015.06.018. Epub 2015 Aug 5. Review.

6.

[L-type fatty acid binding protein (L-FABP) and kidney disease].

Kamijo-Ikemori A, Sugaya T, Kimura K.

Rinsho Byori. 2014 Feb;62(2):163-70. Review. Japanese.

PMID:
24800492
7.

Update on biomarkers of acute kidney injury: moving closer to clinical impact?

Schiffl H, Lang SM.

Mol Diagn Ther. 2012 Aug 1;16(4):199-207. doi: 10.2165/11634310-000000000-00000. Review.

PMID:
22650449
8.

Pre-procedural glucose levels and the risk for contrast-induced acute kidney injury in patients undergoing coronary angiography.

Stolker JM, McCullough PA, Rao S, Inzucchi SE, Spertus JA, Maddox TM, Masoudi FA, Xiao L, Kosiborod M.

J Am Coll Cardiol. 2010 Apr 6;55(14):1433-40. doi: 10.1016/j.jacc.2009.09.072. Review.

9.

Urinary liver type fatty acid binding protein in diabetic nephropathy.

Kamijo-Ikemori A, Sugaya T, Ichikawa D, Hoshino S, Matsui K, Yokoyama T, Yasuda T, Hirata K, Kimura K.

Clin Chim Acta. 2013 Sep 23;424:104-8. doi: 10.1016/j.cca.2013.05.020. Epub 2013 May 30. Review.

10.

Cystatin C in prediction of acute kidney injury: a systemic review and meta-analysis.

Zhang Z, Lu B, Sheng X, Jin N.

Am J Kidney Dis. 2011 Sep;58(3):356-65. doi: 10.1053/j.ajkd.2011.02.389. Epub 2011 May 20. Review. Erratum in: Am J Kidney Dis. 2012 Apr;59(4):590-2.

PMID:
21601330
11.

Roles of human liver type fatty acid binding protein in kidney disease clarified using hL-FABP chromosomal transgenic mice.

Kamijo-Ikemori A, Sugaya T, Matsui K, Yokoyama T, Kimura K.

Nephrology (Carlton). 2011 Aug;16(6):539-44. doi: 10.1111/j.1440-1797.2011.01469.x. Review.

PMID:
21504508
12.

Sodium bicarbonate therapy for the prevention of contrast-induced acute kidney injury – a systematic review and meta-analysis –.

Jang JS, Jin HY, Seo JS, Yang TH, Kim DK, Kim TH, Urm SH, Kim DS, Kim DK, Seol SH, Kim DI, Cho KI, Kim BH, Park YH, Je HG, Ahn JM, Kim WJ, Lee JY, Lee SW.

Circ J. 2012;76(9):2255-65. Epub 2012 Jun 7. Review.

13.

Subclinical acute kidney injury (AKI) due to iodine-based contrast media.

Ronco C, Stacul F, McCullough PA.

Eur Radiol. 2013 Feb;23(2):319-23. doi: 10.1007/s00330-012-2607-y. Epub 2012 Aug 16. Review.

PMID:
22895617
14.

Urinary liver fatty acid-binding protein: another novel biomarker of acute kidney injury.

McMahon BA, Murray PT.

Kidney Int. 2010 Apr;77(8):657-9. doi: 10.1038/ki.2010.5. Review.

15.

Renalguard system in high-risk patients for contrast-induced acute kidney injury.

Briguori C.

Minerva Cardioangiol. 2012 Jun;60(3):291-7. Review.

PMID:
22653043
16.

L-FABP: A novel biomarker of kidney disease.

Xu Y, Xie Y, Shao X, Ni Z, Mou S.

Clin Chim Acta. 2015 May 20;445:85-90. doi: 10.1016/j.cca.2015.03.017. Epub 2015 Mar 20. Review.

PMID:
25797895
17.

Frequency of acute kidney injury following intravenous contrast medium administration: a systematic review and meta-analysis.

McDonald JS, McDonald RJ, Comin J, Williamson EE, Katzberg RW, Murad MH, Kallmes DF.

Radiology. 2013 Apr;267(1):119-28. doi: 10.1148/radiol.12121460. Epub 2013 Jan 14. Review.

PMID:
23319662
18.

Contrast-induced acute kidney injury: how much contrast is safe?

Keaney JJ, Hannon CM, Murray PT.

Nephrol Dial Transplant. 2013 Jun;28(6):1376-83. doi: 10.1093/ndt/gfs602. Epub 2013 Feb 14. Review.

PMID:
23413087
19.

[Disease biomarkers for CKD].

Mori K, Mukoyama M, Kasahara M, Yokoi H, Nakao K.

Nihon Rinsho. 2012 May;70(5):864-8. Review. Japanese.

PMID:
22620014
20.

Urinary fatty acid-binding protein 1: an early predictive biomarker of kidney injury.

Noiri E, Doi K, Negishi K, Tanaka T, Hamasaki Y, Fujita T, Portilla D, Sugaya T.

Am J Physiol Renal Physiol. 2009 Apr;296(4):F669-79. doi: 10.1152/ajprenal.90513.2008. Epub 2008 Nov 19. Review.

Supplemental Content

Support Center